JPMorgan U.S. Research Enhanced Large Cap ETF
JUSA
3 hedge funds and large institutions have $13.7M invested in JPMorgan U.S. Research Enhanced Large Cap ETF in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
2% more capital invested
Capital invested by funds: $13.4M → $13.7M (+$248K)
3.23% less ownership
Funds ownership: 52.49% → 49.26% (-3.2%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$387K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$474K |
JUSA Hedge Fund Activity: Q4 2025 in Review
3 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) for Q4 2025, worth a combined $13.7M — up 1.8% from $13.4M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new JUSA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $387K. The largest seller was Tower Research Capital (TRC), cutting an estimated $474K.
- 3 institutional investors held JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) as of Q4 2025, up from 2 in Q3 2025.
- Funds reported $13.7M of JPMorgan U.S. Research Enhanced Large Cap ETF stock for Q4 2025, up 1.8% quarter-over-quarter.
- 1 fund opened new JPMorgan U.S. Research Enhanced Large Cap ETF positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest JPMorgan U.S. Research Enhanced Large Cap ETF buyer in Q4 2025 was Goldman Sachs, an estimated $387K added.
- The largest JPMorgan U.S. Research Enhanced Large Cap ETF seller in Q4 2025 was Tower Research Capital (TRC), an estimated $474K sold.
Based on aggregated 13F filings for Q4 2025.